본문 바로가기

추천 검색어

실시간 인기 검색어

학술논문

Feasibility and safety study of ultra-hypofractionated neoadjuvant radiotherapy to margins-at-risk in retroperitoneal sarcoma

이용수  0

영문명
발행기관
대한방사선종양학회
저자명
Ru-Xin Wong Valerie Shi Wen Yang Clarame Shulyn Chia Wen Shen Looi Wen Long Nei Chin-Ann Johnny Ong
간행물 정보
『대한방사선종양학회지』제43권 제1호, 6~12쪽, 전체 7쪽
주제분류
의약학 > 종양학
파일형태
PDF
발행일자
2025.03.31
4,000

구매일시로부터 72시간 이내에 다운로드 가능합니다.
이 학술논문 정보는 (주)교보문고와 각 발행기관 사이에 저작물 이용 계약이 체결된 것으로, 교보문고를 통해 제공되고 있습니다.

1:1 문의
논문 표지

국문 초록

Purpose: Retroperitoneal sarcomas (RPS) are rare tumors that present unique challenges, often due to late presentation, and the proximity of critical organs makes complete surgical resection challenging. This study aimed to assess the feasibility of neoadjuvant short-course radiotherapy (SCRT) targeting margins-at-risk and to assess its potential impact on outcomes. Materials and Methods: This is a single-center, prospective, non-randomized feasibility study. SCRT was administered via image-guided volumetric modulated arc therapy, consisting of 5 fractions of daily radiotherapy followed by immediate surgery. As a starting dose, patients were prescribed 25 Gy in 5 fractions. For the escalation stage, patients were prescribed 30 Gy in 5 fractions. Only the presumed threatened surgical margins were delineated for large tumors. Results: Patients with either primary or recurrent RPS were recruited. Eight patients underwent SCRT but one patient did not have a resection as planned. Seven patients underwent surgical resection, of whom one passed away 3 months postoperative from a cardiac event. After a median follow-up of 20.5 months for the six postoperative survivors, there were no overt long-term toxicities and one patient relapsed out-of-radiotherapy-field. Conclusion: SCRT to RPS with a margin boost followed by immediate surgery is worth investigating. A starting dose of 30 Gy in 5 fractions is recommended for further studies. Longer-term follow-up is necessary.

영문 초록

목차

Introduction
Materials and Methods
Results
Discussion and Conclusion
Statement of Ethics
Conflict of Interest
Acknowledgments
Funding
Author Contributions
Data Availability Statement
References

키워드

해당간행물 수록 논문

참고문헌

교보eBook 첫 방문을 환영 합니다!

신규가입 혜택 지급이 완료 되었습니다.

바로 사용 가능한 교보e캐시 1,000원 (유효기간 7일)
지금 바로 교보eBook의 다양한 콘텐츠를 이용해 보세요!

교보e캐시 1,000원
TOP
인용하기
APA

Ru-Xin Wong,Valerie Shi Wen Yang,Clarame Shulyn Chia,Wen Shen Looi,Wen Long Nei,Chin-Ann Johnny Ong. (2025).Feasibility and safety study of ultra-hypofractionated neoadjuvant radiotherapy to margins-at-risk in retroperitoneal sarcoma. 대한방사선종양학회지, 43 (1), 6-12

MLA

Ru-Xin Wong,Valerie Shi Wen Yang,Clarame Shulyn Chia,Wen Shen Looi,Wen Long Nei,Chin-Ann Johnny Ong. "Feasibility and safety study of ultra-hypofractionated neoadjuvant radiotherapy to margins-at-risk in retroperitoneal sarcoma." 대한방사선종양학회지, 43.1(2025): 6-12

결제완료
e캐시 원 결제 계속 하시겠습니까?
교보 e캐시 간편 결제